- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07738627
Effects of IMT on Cardiopulmonary Endurance and Functional Mobility in KOA (IMT)
August 25, 2026 updated by: Riphah International University
Inspiratory Muscle Training as an Adjunct to Standard Care: Effects on Cardiopulmonary Endurance and Functional Mobility in Knee Osteoarthritis
The purpose of the study is to investigate whether adding Inspiratory Muscle Training (IMT) to the usual treatment of patients with knee osteoarthritis improves their cardiopulmonary endurance and functional mobility more than standard care alone.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Knee osteoarthritis (KOA) is a common degenerative joint disorder associated with pain, stiffness, reduced mobility, and decreased physical activity.
Reduced activity levels often result in impaired cardiopulmonary fitness and decreased aerobic capacity.
Previous evidence suggests that individuals with severe KOA exhibit diminished inspiratory muscle strength and lower exercise tolerance.
Inspiratory Muscle Training (IMT) strengthens respiratory muscles and improves ventilatory efficiency.
IMT is a technique in which a person breathes in against resistance using a special device such as POWERbreathe to make the breathing muscles stronger.
Since conventional rehabilitation primarily focuses on pain reduction and lower limb strengthening, incorporating IMT may provide additional benefits without imposing extra stress on the knee joint.
This study aims to compare conventional KOA treatment combined with IMT against conventional treatment combined with sham IMT over a six-week intervention period.
Study Type
Interventional
Enrollment (Estimated)
65
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Dr. Suman Sheraz, Phd
- Phone Number: 03335646361
- Email: suman.sheraz@riphah.edu.pk
Study Contact Backup
- Name: Dr. Imran Amjad, Phd
- Phone Number: 03324390125
- Email: imran.amjad@riphah.edu.pk
Study Locations
-
-
Punjab Province
-
Rawalpindi, Punjab Province, Pakistan, 46060
- IIMCT Railway general hospital
-
Contact:
- Dr Imran Amjad, PhD
- Phone Number: 03324390125
- Email: imran.amjad@riphah.edu.pk
-
Contact:
- Dr Suman Sheraz, PhD
- Phone Number: 03335646361
- Email: suman.sheraz@riphah.edu.pk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 40-65 years
- Male and Female participants
- Bilateral Knee Osteoarthritis
- Diagnosed according to American College of Rheumatology criteria
- Kellgren and Lawrence Grade II-III
- Able to walk independently
- Willing to provide informed consent
Exclusion Criteria:
- Participation in structured physical activity programs
- Intra-articular corticosteroid injection within last 3 months
- Hyaluronic acid injection within last 6 months
- Lower limb trauma or surgery history
- Planned surgery during study period
- Severe cardiovascular disease
- Severe pulmonary disease
- Neurological disorders
- Psychological disorders
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Inspiratory Muscle Training (IMT) + Conventional Knee OA Physiotherapy
Participants will receive conventional knee osteoarthritis physiotherapy twice weekly for 6 weeks along with Inspiratory Muscle Training (IMT) using a POWERbreathe device.
IMT will consist of 30 quick breaths twice daily at approximately 50% of baseline maximal inspiratory pressure (MIP), progressively increased up to 35 breaths according to patient tolerance.
Conventional treatment includes knee isometric exercises, open-chain strengthening exercises, static stretching, and Maitland Grade I-II anterior-posterior mobilizations.
|
The POWERBREATH devices utilize calibrated resistance valves to force your breathing muscles to work harder, which naturally builds their power, stamina, and efficiency. IMT through POWERbreathe
|
|
Sham Comparator: Sham IMT + Conventional Knee OA Physiotherapy
Participants will receive conventional knee osteoarthritis physiotherapy twice weekly for 6 weeks along with sham inspiratory muscle training using a POWERbreathe device.
Sham training will consist of 60 slow breaths once daily at load setting zero (approximately 15% of baseline MIP).
The load adjuster will be fixed with adhesive tape to prevent resistance progression.
Conventional treatment will be identical to the experimental group
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Six-Minute Walk Test Assessment of cardiopulmonary endurance and aerobic capacity. Time Frame: Baseline, Week 3, Week 6 Six-Minute Walk Test (6MWT) Assessment of cardiopulmonary endurance and aerobic capacity. Time Frame: Baseline, Week 3, Wee
Time Frame: Baseline, Week 3, Week 6
|
Assessment of cardiopulmonary endurance
|
Baseline, Week 3, Week 6
|
|
. Timed Up and Go Test (TUG)
Time Frame: Time Frame: Baseline, Week 3, Week 6
|
Assessment of funcional mobility.
|
Time Frame: Baseline, Week 3, Week 6
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analogue Scale (VAS)
Time Frame: : Baseline, Week 3, Week 6
|
Pain intensity was measured using the Visual Analog Scale (VAS), with scores ranging from 0 (no pain) to 10 (worst imaginable pain).
The minimum possible score is 0, the maximum possible score is 10, and higher scores represent greater pain intensity (worse outcome).
|
: Baseline, Week 3, Week 6
|
|
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Time Frame: Baseline, Week 3, Week 6
|
Assessment of pain, stiffness, physical function, and quality of life.
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score: The WOMAC is a self-reported questionnaire assessing pain, stiffness, and physical function in individuals with osteoarthritis.
The total score ranges from 0 to 96, where 0 indicates no symptoms or functional impairment and 96 indicates the most severe symptoms and functional impairment.
Higher scores indicate a worse outcome.
|
Baseline, Week 3, Week 6
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Dr. Suman Sheraz, PhD, Riphah International University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
August 1, 2026
Primary Completion (Estimated)
January 5, 2027
Study Completion (Estimated)
December 11, 2027
Study Registration Dates
First Submitted
July 28, 2026
First Submitted That Met QC Criteria
July 28, 2026
First Posted (Actual)
July 31, 2026
Study Record Updates
Last Update Posted (Actual)
August 27, 2026
Last Update Submitted That Met QC Criteria
August 25, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Shagufta
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.